Literature DB >> 34707967

Mechanisms of Lower Urinary Tract Symptoms in Pelvic Ischemia.

Kazem M Azadzoi1, Mike B Siroky1.   

Abstract

The etiology of lower urinary tract symptoms is poorly understood. The pathophysiology of detrusor instability, voiding dysfunction and pelvic pain in patients with non-obstructed bladder remains highly controversial. In the male, most cases of lower urinary tract symptoms are attributed to bladder outlet obstruction due to benign prostatic hyperplasia. However, urodynamic data have revealed that in approximately one third to more than one half of cases, lower urinary tract symptoms are not associated with enlarged prostate or bladder outlet obstruction. Interestingly, lower urinary tract symptoms questionnaires in women yield scores that are similar to their age-matched male counterparts. These observations imply that aging-associated sex-independent changes in bladder vasculature, nerves, smooth muscle and epithelium may play a role in the development of lower urinary tract symptoms. Epidemiologic studies have shown a close correlation between vascular occlusive disorders and the prevalence of lower urinary tract symptoms. International prostate symptom scores were found to be significantly worse in men with cardiovascular disorders than symptomatic patients without cardiovascular problems. Clinical trials have revealed a close correlation between decreased pelvic blood flow and severity of lower urinary tract symptoms in the elderly patients. Studies with experimental models of pelvic ischemia have shown that accumulation of reactive oxygen species in the ischemic bladder initiates a cascade of cellular, subcellular and molecular reactions. These reactions to ischemia appear to compromise bladder structure and function leading to neurodegeneration, smooth muscle instability, increased contractile activity, fibrosis and non-compliance. These observations collectively introduce a new concept in the pathophysiology of voiding dysfunction suggesting that pelvic ischemia may be an independent factor in the development of non-obstructed non-neurogenic overactive bladder and lower urinary tract symptoms.

Entities:  

Keywords:  LUTS; ischemia; overactive bladder; oxidative stress

Year:  2013        PMID: 34707967      PMCID: PMC8547274     

Source DB:  PubMed          Journal:  J Biochem Pharmacol Res


  67 in total

Review 1.  Chemistry and biochemistry of oxidative stress in neurodegenerative disease.

Authors:  L M Sayre; M A Smith; G Perry
Journal:  Curr Med Chem       Date:  2001-06       Impact factor: 4.530

Review 2.  Endothelial cell apoptosis in angiogenesis and vessel regression.

Authors:  S Dimmeler; A M Zeiher
Journal:  Circ Res       Date:  2000-09-15       Impact factor: 17.367

3.  Quantitative morphometry of the adult human bladder.

Authors:  H Lepor; I Sunaryadi; V Hartanto; E Shapiro
Journal:  J Urol       Date:  1992-08       Impact factor: 7.450

Review 4.  Medical therapy for benign prostatic hyperplasia.

Authors:  H Lepor
Journal:  Urology       Date:  1993-11       Impact factor: 2.649

5.  Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis.

Authors:  H L Rittner; V Hafner; P A Klimiuk; L I Szweda; J J Goronzy; C M Weyand
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

6.  Focal hypoxia of the obstructed rabbit bladder wall correlates with intermediate decompensation.

Authors:  Robert M Levin; Laura J O'Connor; Robert E Leggett; Catherine Whitbeck; Paul Chichester
Journal:  Neurourol Urodyn       Date:  2003       Impact factor: 2.696

Review 7.  The relationship between erectile dysfunction and lower urinary tract symptoms and the role of phosphodiesterase type 5 inhibitors.

Authors:  Tobias S Köhler; Kevin T McVary
Journal:  Eur Urol       Date:  2008-09-04       Impact factor: 20.096

8.  Pelvic ischemia is measurable and symptomatic in patients with coronary artery disease: a novel application of dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Elise J B De; Ping Hou; Anthony L Estrera; Stefano Sdringola; Larry A Kramer; Daniel E Graves; O Lenaine Westney
Journal:  J Sex Med       Date:  2008-08-26       Impact factor: 3.802

9.  Antioxidant SOD mimetic prevents NADPH oxidase-induced oxidative stress and renal damage in the early stage of experimental diabetes and hypertension.

Authors:  Elisa B M I Peixoto; Bruno S Pessoa; Subrata K Biswas; Jose B Lopes de Faria
Journal:  Am J Nephrol       Date:  2008-10-11       Impact factor: 3.754

10.  Effects of ischemia on tachykinin-containing nerves and neurokinin receptors in the rabbit bladder.

Authors:  Kazem M Azadzoi; Ziv M Radisavljevic; Mike B Siroky
Journal:  Urology       Date:  2008-03-07       Impact factor: 2.649

View more
  2 in total

1.  Does metabolic syndrome influence the efficacy of mirabegron treatment in female patients with overactive bladder?

Authors:  Manami Kinjo; Kazuki Masuda; Yu Nakamura; Satoru Taguchi; Mitsuhiro Tambo; Hiroshi Fukuhara
Journal:  Int Urogynecol J       Date:  2022-06-14       Impact factor: 2.894

Review 2.  Purine nucleoside phosphorylase as a target to treat age-associated lower urinary tract dysfunction.

Authors:  Lori A Birder; Edwin K Jackson
Journal:  Nat Rev Urol       Date:  2022-09-07       Impact factor: 16.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.